BusinessWeek: [Nov. 23] "Drugmaker Gilead Sciences Inc. said Tuesday it asked the Food and Drug Administration to approve a single pill combination of its HIV treatment Truvada and Tibotec Pharmaceuticals' rilpivirine.
"The companies have been working together to develop the combination since July of 2009."
0 comments:
Post a Comment